Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa
- PMID: 156240
Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa
Abstract
Mutagenicity and mutagenic specificity of niridazole and metronidazole, two chemotherapeutic agents used in the treatment of human parasitic diseases, were studied with the ad-3 test system of Neurospora crassa. The results show that neither compound is mutagenic in resting conidia. In growing vegetative cells, however, both compounds are mutagenic in Neurospora crassa. Genetic analysis of the mutants indicate that niridazole induces predominantly base-pair substitution mutations. None of the niridazole-induced mutants resulted from multilocus deletions. The spectra of genetic alterations induced by metronidazole are similar to those induced by the monofunctional alkylating agents, EI, EMS and ICR-177. It is suggested, therefore, that the mechanism of mutation induction by metronidazole in Neurospora is similar to that of monofunctional alkylating agents.
Similar articles
-
Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.J Toxicol Environ Health. 1978 Sep-Nov;4(5-6):815-24. doi: 10.1080/15287397809529702. J Toxicol Environ Health. 1978. PMID: 153406
-
Genetic characterization of adenine-3 mutants induced by 4-nitroquinoline 1-oxide and 4-hydroxyaminoquinoline 1-oxide in Neurospora crassa.Cancer Res. 1975 Feb;35(2):291-5. Cancer Res. 1975. PMID: 122814
-
Mutagenic evaluation of antischistosomal drugs and their derivatives in Neurospora crassa.J Toxicol Environ Health. 1975 Nov;1(2):271-9. doi: 10.1080/15287397509529326. J Toxicol Environ Health. 1975. PMID: 128637
-
Utilization of the specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora for risk assessment of environmental chemicals.Mutat Res. 1991 Sep-Oct;250(1-2):251-74. doi: 10.1016/0027-5107(91)90182-n. Mutat Res. 1991. PMID: 1834935 Review.
-
Characteristics of spontaneous and induced specific-locus mutation in the ad-3 region of Neurospora crassa: utilization in genetic risk assessment.Environ Mol Mutagen. 1992;20(4):246-59. doi: 10.1002/em.2850200403. Environ Mol Mutagen. 1992. PMID: 1425607 Review.
Cited by
-
Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis.Environ Health Perspect. 1985 Dec;64:199-208. doi: 10.1289/ehp.8564199. Environ Health Perspect. 1985. PMID: 3830698 Free PMC article.
-
Genetic risk assessment and specific-locus mutations in the ad-3 region of Neurospora crassa.Environ Health Perspect. 1994 Jan;102 Suppl 1(Suppl 1):83-90. doi: 10.1289/ehp.94102s183. Environ Health Perspect. 1994. PMID: 8187730 Free PMC article.